FIM
CORT icon

Freedom Investment Management’s Corcept Therapeutics CORT Stock Holding History

Freedom Investment Management’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-9,194
Closed -$219K – 879
2021
Q1 		$219K Buy
+9,194
New +$245K 0.02% 759
2020
Q4 		– Sell
-13,159
Closed -$229K – 623
2020
Q3 		$229K Buy
+13,159
New +$210K 0.02% 476
2019
Q1 		– Sell
-28,358
Closed -$379K – 699
2018
Q4 		$379K Sell
28,358
-2,343
-8% -$31K 0.03% 492
2018
Q3 		$461K Buy
30,701
+5,151
+20% +$72K 0.03% 546
2018
Q2 		$402K Buy
+25,550
New +$444K 0.02% 649

Other funds holding CORT

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.82B AUM 21.61% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.55B AUM 17.89% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return